إعلان
إعلان
LXRX
Lexicon Pharmaceuticals, Inc.
1.18
USDبرعاية
0.00
-0.42%
٠٩ يناير, ١٥:٢٦ UTC -5
مغلق
بعد الإغلاق
1.19
+0.01
+1.28%
تقارير أرباح LXRX
النسبة الإيجابية المفاجئة
LXRX تفوق 34 من 40 آخر التقديرات.
85%
التقرير التالي
بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$3.20M
/-$0.07
التغير الضمني من Q3 25 (Revenue/ EPS)
-77.40%
/+75.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-87.93%
/-22.22%
Lexicon Pharmaceuticals, Inc. earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, LXRX reported earnings of -0.04 USD per share (EPS) for Q3 25, beating the estimate of -0.06 USD, resulting in a 40.56% surprise. Revenue reached 14.18 مليون, compared to an expected 4.74 مليون, with a 199.06% difference. The market reacted with a +3.62% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of -0.07 USD, with revenue projected to reach 3.20 مليون USD, implying an زيادة of 75.00% EPS, and نقصان of -77.40% in Revenue from the last quarter.
الأسئلة الشائعة
What were Lexicon Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lexicon Pharmaceuticals, Inc. reported EPS of -$0.04, beating estimates by 40.56%, and revenue of $14.18M, 199.06% above expectations.
How did the market react to Lexicon Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 3.62%, changed from $1.38 before the earnings release to $1.43 the day after.
When is Lexicon Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
What are the forecasts for Lexicon Pharmaceuticals, Inc.'s next earnings report?
Based on 7
المحللين, Lexicon Pharmaceuticals, Inc. is expected to report EPS of -$0.07 and revenue of $3.20M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان